The civic record
Read. Follow. Verify.Missouri House Bill 2067 Modifies Prescriptive Authority and Collaborative Practice Rules for Advanced Practice Registered Nurses
Last action · May 15, 2026: Referred: Emerging Issues(H)Sponsor: David Casteel
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
This bill modifies provisions relating to the prescriptive authority of advanced practice registered nurses (APRNs) and their s with physicians. It sets specific limits on controlled substance prescriptions, chart reviews, geographic proximity waivers, and physician-to-nurse supervision ratios.
Changes how advanced practice registered nurses collaborate with physicians and prescribe controlled substances, directly impacting healthcare providers, clinic staffing, and patient medication access across Missouri.
- Advanced practice registered nurses (APRNs) in Missouri operate under collaborative practice arrangements with licensed physicians to provide patient care and prescribe medications. context
- The Missouri General Assembly considers legislation annually to update statutory scopes of practice and supervisory requirements for healthcare professionals. context
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Advanced Practice Registered Nurses
Their prescriptive authorities, chart review obligations, supervision ratios, and collaborative practice agreement rules are modified.
Collaborating Physicians
Their supervisory limits, mandatory chart review percentages, geographic proximity rules, and right of refusal regarding collaborative practice are regulated.
Hospice Patients
They are eligible to receive Schedule II controlled substance prescriptions from qualified collaborating APRNs employed by certified hospice providers.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What controlled substances are advanced practice registered nurses allowed to prescribe?
Can a physician be forced to enter into a collaborative practice arrangement with an APRN?
How often must patient charts be reviewed by the collaborating physician?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently in committee. The next step in the legislative lifecycle is Floor Vote.
Procedural history
4 actions- May 15, 2026HouseCommitteeReferred: Emerging Issues(H)
- Jan 8, 2026HouseFloorRead Second Time (H)
- Jan 7, 2026HouseIntroducedRead First Time (H)
- Dec 1, 2025HouseIntroducedPrefiled (H)
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Expanded Prescription and Supervision Guidelines
The measure establishes precise statutory boundaries for APRN prescriptive authority over Schedule II substances, buprenorphine, and hospice medications while setting strict physician oversight limits.
Connected Entities
Sources
house.mo.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy60Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz35Current news / social attention level
Publisher tools